![Wilson Totten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Wilson Totten served as the Chief Executive Officer of Kyowa Kirin International Plc from 2004 to 2010.
He also worked as a Non-Executive Director at Galapagos NV.
Eerdere bekende functies van Wilson Totten
| Bedrijven | Functie | Einde |
|---|---|---|
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases | President | 07-09-2010 |
| LAKEFRONT BIOTHERAPEUTICS NV | Directeur/Bestuurslid | 23-12-2006 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases | Health Technology |
